Sonora Investment Management Group, LLC Spectrum Pharmaceuticals Inc Transaction History

Sonora Investment Management Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$0.65 - $1.31 $130 - $262	-200 Reduced 0.19%	103,000 $98,000
Q1 2023 May 12, 2023	BUY	$0.38 - $1.07 $76 - $214	200 Added 0.19%	103,200 $77,000
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.4 $14,699 - $29,399	21,000 Added 25.61%	103,000 $80,000
Q4 2021 Feb 11, 2022	BUY	$1.27 - $2.42 $104,140 - $198,440	82,000 New	82,000 $104,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Sonora Investment Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Sonora Investment Management Group, LLC with notifications on news.